Cue Biopharma, Inc. (CUE) Tops Q2 EPS by 2c

Cue Biopharma, Inc. (NASDAQ: CUE) reported Q2 EPS of ($0.29), $0.02 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $1.38 million versus the consensus estimate of $907.5 thousand.

For earnings history and earnings-related data on Cue Biopharma, Inc. (CUE) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance